Psychopharmacology Bulletin · 2025 · 29 citations · 15 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyDopaminergic PharmacologyNeurologic EmergenciesAltered Consciousness Evaluation
Neuroleptic malignant syndrome is a rare, idiosyncratic emergency associated with exposure to dopamine antagonists, commonly antipsychotic drugs. The typical clinical picture consists of altered consciousness, muscular rigidity, fever, and autonomic instability. While the condition has generally been well described, the pathophysiology is still poorly understood. The importance of this case report is to highlight the lack of robust evidence-based treatment for this emergency. We submit an approach to the pharmacotherapy of neuroleptic malignant syndrome based on the available evidence.
15
Neuroleptic malignant syndrome
Victor W. Henderson, G. Frederick Wooten · Neurology · 1981 · 343 citations
Medicine, Neurology, Pharmacology +16
Dantrolene in Human Malignant Hyperthermia A Multicenter Study
Mary Elizabeth Kolb, M. L. Horne, Robert Martz · Anesthesiology · 1982 · 295 citations · Full text
Progression of Symptoms in Neuroleptic Malignant Syndrome
Varadaraj R. Velamoor, Ross Norman, Stanley N. Caroff et al. · The Journal of Nervous and Mental Disease · 1994 · 151 citations
Medicine, Neurology, Psychiatry +9
Drug treatment of the neuroleptic malignant syndrome.
P. Sakkas, J M Davis, Philip G. Janicak et al. · PubMed · 1991 · 117 citations